ORIGINAL RESEARCH
Published on 20 Dec 2019
OSbrca: A Web Server for Breast Cancer Prognostic Biomarker Investigation With Massive Data From Tens of Cohorts
doi 10.3389/fonc.2019.01349
- 7,634 views
- 24 citations
- Frontiers in Oncology
- Cancer Genetics
- Research Topics
- New Approaches to Classification and Diagnostic Prediction of Breast Cancers
New Approaches to Classification and Diagnostic Prediction of Breast Cancers
28k
Total downloads
124k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 03 Dec 2019
7-lncRNA Assessment Model for Monitoring and Prognosis of Breast Cancer Patients: Based on Cox Regression and Co-expression Analysis
doi 10.3389/fonc.2019.01348
- 3,470 views
- 38 citations
ORIGINAL RESEARCH
Published on 05 Nov 2019
Different Pathological Complete Response Rates According to PAM50 Subtype in HER2+ Breast Cancer Patients Treated With Neoadjuvant Pertuzumab/Trastuzumab vs. Trastuzumab Plus Standard Chemotherapy: An Analysis of Real-World Data
doi 10.3389/fonc.2019.01178
- 4,383 views
- 13 citations
REVIEW
Published on 29 Oct 2019
Deciphering HER2 Breast Cancer Disease: Biological and Clinical Implications
doi 10.3389/fonc.2019.01124
- 18,467 views
- 73 citations
SYSTEMATIC REVIEW
Published on 17 Oct 2019
Prognostic Value of Ki-67 in Patients With Resected Triple-Negative Breast Cancer: A Meta-Analysis
doi 10.3389/fonc.2019.01068
- 13,333 views
- 57 citations
ORIGINAL RESEARCH
Published on 04 Oct 2019
ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control
doi 10.3389/fgene.2019.00790
- 2,582 views
- 21 citations
ORIGINAL RESEARCH
Published on 01 Oct 2019
Two Distinct Subtypes Revealed in Blood Transcriptome of Breast Cancer Patients With an Unsupervised Analysis
doi 10.3389/fonc.2019.00985
- 4,382 views
- 17 citations
CORRECTION
Published on 25 Sep 2019
Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution
doi 10.3389/fonc.2019.00967
- 1,177 views
- 1 citation
ORIGINAL RESEARCH
Published on 06 Aug 2019
PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution
doi 10.3389/fonc.2019.00707
- 4,529 views
- 17 citations
ORIGINAL RESEARCH
Published on 24 Jul 2019
Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer
doi 10.3389/fonc.2019.00667
- 5,718 views
- 12 citations
MINI REVIEW
Published on 23 Jul 2019
Mechanisms of Resistance to CDK4/6 Inhibitors: Potential Implications and Biomarkers for Clinical Practice
doi 10.3389/fonc.2019.00666
- 33,496 views
- 135 citations
ORIGINAL RESEARCH
Published on 09 Jul 2019
TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway
doi 10.3389/fonc.2019.00617
- 3,023 views
- 30 citations
Published in
Frontiers in Oncology
Women's Cancer
OfflineCancer Genetics
Cancer Molecular Targets and Therapeutics
Participating Journals
Frontiers in Genetics
Cancer Genetics
- 2.8 impact factor
- 5.5 citescore